| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.022 | 0.9 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.9 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.017 | 0.9 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.0091 | 0.9 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.9 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.008 | 0.9 |